683 Capital Management’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

683 Capital Management’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-335,754	Closed	-$107K	–	152
2025 Q1	$107K	Sell	335,754 -159,921	-32%	-$40.9K	0.01%	131
2024 Q4	$114K	Sell	495,675 -100	-0%	-$13	0.01%	215
2024 Q3	$48.5K	Sell	495,775 -112,908	-19%	-$19.8K	﹤0.01%	117
2024 Q2	$97.4K	Sell	608,683 -2,040	-0.3%	-$417	0.01%	112
2024 Q1	$185K	Sell	610,723 -224,600	-27%	-$26.7K	0.01%	101
2023 Q4	$50.1K	Hold	835,323	–	–	﹤0.01%	225
2023 Q3	$83.5K	Hold	835,323	–	–	0.01%	115
2023 Q2	$138K	Hold	835,323	–	–	0.01%	116
2023 Q1	$100K	Hold	835,323	–	–	0.01%	228
2022 Q4	$121K	Hold	835,323	–	–	0.01%	229
2022 Q3	$167K	Hold	835,323	–	–	0.01%	148
2022 Q2	$234K	Hold	835,323	–	–	0.02%	170
2022 Q1	$674K	Buy	835,323 +10,000	+1%	+$10.1K	0.04%	183
2021 Q4	$1.56M	Hold	825,323	–	–	0.06%	147
2021 Q3	$2.11M	Hold	825,323	–	–	0.08%	112
2021 Q2	$2.15M	Hold	825,323	–	–	0.07%	122
2021 Q1	$2.2M	Buy	+825,323	New	+$2.39M	0.12%	101

Other funds holding NUVB.WS

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

GCM

Greenland Capital Management New York $812M AUM 45.54% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

683 Capital Management's NUVB.WS Position: Q2 2025 in Review

683 Capital Management sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q2 2025, closing a stake of 335,754 shares — an estimated $107K sold.

683 Capital Management first reported a position in NUVB.WS in Q1 2021 and held it in 17 quarters. The position peaked at $2.2M in Q1 2021. 21 funds tracked by Wall St. Rank hold NUVB.WS as of Q2 2025.

683 Capital Management reported no remaining Nuvation Bio Inc Warrants position as of Q2 2025 after selling out during the quarter.
683 Capital Management sold 335,754 Nuvation Bio Inc Warrants shares in Q2 2025, an estimated $107K.
683 Capital Management first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 17 quarters.
683 Capital Management's Nuvation Bio Inc Warrants position peaked at $2.2M in Q1 2021.
21 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q2 2025.

Based on 683 Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.